Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
FR00140048X2
Wed, 12.10.2022
Ikonisys SA
Mandatory convertible bond
The issuance of a mandatory convertible bond with warrants attached
provides Ikonisys with the liquidity needed for the global commercial
roll-out strategy of the Ikoniscope20 and the further development of the
microscopy platform into a state-of-the-art Artificial Intelligence system,
in our view. In addition, Ik [ … ]
Thu, 23.06.2022
Ikonisys SA
First sale of Ikoniscope20
Ikonisys has announced the first sale of its Ikoniscope20 microscope
solution together with reagents. The sale is, in our view, a first proof
that the commercialization strategy of migrating existing users of
Ikonisys' former Ikoniscope Gen1 platform into users of the state-of-art
Ikoniscope20 technology is correctly c [ … ]
Mon, 09.05.2022
Ikonisys SA
New significant shareholder through convertible bond
With the issuance of a de facto mandatory convertible bond, Ikonisys has,
in our view, found a smart solution to one of its major problems: Funding
the market entry of Ikoniscope20 in the US and Europe and funding the
further development of the microscope platform into a state-of-the-art
artif [ … ]
Wed, 09.02.2022
Ikonisys SA
Important client-win in Italy
After the first sale of the new-gen microscope, the Ikoniscope20, to one of
the biggest genetic laboratories in Italy, we confirm our Buy rating for
the shares of Ikonisys and our three-stage discounted cash flow entity
model (primary valuation method) share price target of EUR 7.70.
Ikonisys announced the sale an [ … ]
Tue, 25.01.2022
Ikonisys SA
Restart of a technology leader in laboratory automation
With a share price target of EUR 7.70 and an expected share price
performance of 176.0%, we initiate research coverage on the shares of
Ikonisys SA with a Buy rating. Our price target is derived from a threestage
discounted cash flow entity model (primary valuation method), for
which we ca [ … ]